Rapamycin Inhibits IGF-1 Stimulated Cell Motility through PP2A Pathway

Lei Liu, Long Chen, Yan Luo et al. · 2010

Read Rapamycin Inhibits IGF-1 Stimulated Cell Motility through PP2A Pathway by Lei Liu, Long Chen, Yan Luo et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0010578.txt.

Description

Lei Liu and colleagues explored how a drug slows moving cells, in PLOS ONE in 2010. The drug was rapamycin, already known to block a growth pathway inside cells. The signal they studied was IGF-1, which normally urges cells to crawl and spread.

Cell experiments showed rapamycin blunted the movement that IGF-1 provokes. The effect ran through a second protein, PP2A, which helps switch other proteins off. Tracing that chain explains part of how rapamycin acts. It also hints at ways to limit the spread of tumor cells, which depend on similar movement signals.

Catalog record

CREATORLei Liu, Long Chen, Yan Luo et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE42 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0010578

Browse the full library · About the Tower of Babel